Literature DB >> 29315295

The role of vaccines in preventing bacterial antimicrobial resistance.

Kathrin U Jansen1, Charles Knirsch1, Annaliesa S Anderson1.   

Abstract

Antimicrobial resistance (AMR) and the associated morbidity and mortality due to bacterial pathogens have been increasing globally to alarming levels. The World Health Organization (WHO) has called for global action on AMR, supported worldwide by governments, health ministries and health agencies. Many potential solutions to stem AMR are being discussed and implemented. These include increases in antimicrobial stewardship, investment in research and development to design new classes of antibiotics, and reduction of antibiotic use in rearing of livestock. However, vaccines as tools to reduce AMR have historically been under-recognized in these discussions, even though their effectiveness in reducing disease and AMR is well documented. This review article seeks to highlight the value of vaccines as an additional modality to combat AMR globally, using select examples. It also will provide perspectives on how vaccines could be more effectively used in this effort.

Mesh:

Substances:

Year:  2018        PMID: 29315295     DOI: 10.1038/nm.4465

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  88 in total

Review 1.  Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries.

Authors:  Robert Cohen; Jérémie François Cohen; Martin Chalumeau; Corinne Levy
Journal:  Expert Rev Vaccines       Date:  2017-04-28       Impact factor: 5.217

Review 2.  A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail.

Authors:  Debra A Goff; Ravina Kullar; Ellie J C Goldstein; Mark Gilchrist; Dilip Nathwani; Allen C Cheng; Kelly A Cairns; Kevin Escandón-Vargas; Maria Virginia Villegas; Adrian Brink; Dena van den Bergh; Marc Mendelson
Journal:  Lancet Infect Dis       Date:  2016-11-18       Impact factor: 25.071

3.  Intrawound vancomycin powder reduces surgical site infections in posterior cervical fusion.

Authors:  Cyrus Caroom; Jessica M Tullar; E Garrison Benton; Jason R Jones; Christopher D Chaput
Journal:  Spine (Phila Pa 1976)       Date:  2013-06-15       Impact factor: 3.468

4.  A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women.

Authors:  Geert Leroux-Roels; Cathy Maes; Julie Willekens; Fien De Boever; Richard de Rooij; Leah Martell; Lisa Bedell; Frederick Wittke; Karen Slobod; Peter Dull
Journal:  Vaccine       Date:  2016-03-05       Impact factor: 3.641

5.  Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.

Authors:  Lee M Hampton; Monica M Farley; William Schaffner; Ann Thomas; Arthur Reingold; Lee H Harrison; Ruth Lynfield; Nancy M Bennett; Susan Petit; Kenneth Gershman; Joan Baumbach; Bernard Beall; James Jorgensen; Anita Glennen; Elizabeth R Zell; Matthew Moore
Journal:  J Infect Dis       Date:  2011-12-07       Impact factor: 5.226

6.  Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.

Authors:  Thomas Tängdén; Britt-Marie Eriksson; Asa Melhus; Bodil Svennblad; Otto Cars
Journal:  J Antimicrob Chemother       Date:  2011-03-04       Impact factor: 5.790

7.  A Retrospective Study on the Protective Effects of Topical Vancomycin in Patients Undergoing Multilevel Spinal Fusion.

Authors:  Marian L Gaviola; Wesley D McMillian; Suzanne Elizabeth Ames; Jeffrey A Endicott; Wallace Kemper Alston
Journal:  Pharmacotherapy       Date:  2016-01-09       Impact factor: 4.705

Review 8.  Staphylococcal vaccines and immunotherapies.

Authors:  Adam C Schaffer; Jean C Lee
Journal:  Infect Dis Clin North Am       Date:  2009-03       Impact factor: 5.982

9.  A comparison of intestinal microbiota in a population of low-risk infants exposed and not exposed to intrapartum antibiotics: The Baby & Microbiota of the Intestine cohort study protocol.

Authors:  Julia Simioni; Eileen K Hutton; Elizabeth Gunn; Alison C Holloway; Jennifer C Stearns; Helen McDonald; Andrea Mousseau; Jonathan D Schertzer; Elyanne M Ratcliffe; Lehana Thabane; Michael G Surette; Katherine M Morrison
Journal:  BMC Pediatr       Date:  2016-11-10       Impact factor: 2.125

10.  Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status.

Authors:  Gonçalo Matias; Robert Taylor; François Haguinet; Cynthia Schuck-Paim; Roger Lustig; Vivek Shinde
Journal:  Influenza Other Respir Viruses       Date:  2014-06-27       Impact factor: 4.380

View more
  60 in total

1.  Safeguarding intestine cells against enteropathogenic Escherichia coli by intracellular protein reaction, a preventive antibacterial mechanism.

Authors:  Jiaming Qiu; Yunyu Nie; Yuan Zhao; Yu Zhang; Linting Li; Rui Wang; Miaomiao Wang; Sheng Chen; Jianhao Wang; Yong-Qiang Li; Jiang Xia
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-24       Impact factor: 11.205

Review 2.  Antimicrobial Resistance in ESKAPE Pathogens.

Authors:  David M P De Oliveira; Brian M Forde; Timothy J Kidd; Patrick N A Harris; Mark A Schembri; Scott A Beatson; David L Paterson; Mark J Walker
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

Review 3.  Antimicrobial resistance: new insights and therapeutic implications.

Authors:  Bashir Ahmad Sheikh; Basharat Ahmad Bhat; Manzoor Ahmad Mir
Journal:  Appl Microbiol Biotechnol       Date:  2022-09-19       Impact factor: 5.560

4.  Microbiome-Independent Effects of Antibiotics in a Murine Model of Nosocomial Infections.

Authors:  Keenan A Lacey; Sandra Gonzalez; Frank Yeung; Gregory Putzel; Magdalena Podkowik; Alejandro Pironti; Bo Shopsin; Ken Cadwell; Victor J Torres
Journal:  mBio       Date:  2022-05-25       Impact factor: 7.786

Review 5.  System Mapping of Antimicrobial Resistance to Combat a Rising Global Health Crisis.

Authors:  Lea Ellen Matthiessen; Tine Hald; Håkan Vigre
Journal:  Front Public Health       Date:  2022-06-17

Review 6.  Cracking the Challenge of Antimicrobial Drug Resistance with CRISPR/Cas9, Nanotechnology and Other Strategies in ESKAPE Pathogens.

Authors:  Tanzeel Zohra; Muhammad Numan; Aamer Ikram; Muhammad Salman; Tariq Khan; Misbahud Din; Muhammad Salman; Ayesha Farooq; Afreenish Amir; Muhammad Ali
Journal:  Microorganisms       Date:  2021-04-29

7.  The well-known and less well-known benefits of vaccines.

Authors:  Jean-Pierre Michel
Journal:  Aging Clin Exp Res       Date:  2020-06-29       Impact factor: 3.636

8.  Fighting Antibiotic-Resistant Klebsiella pneumoniae with "Sweet" Immune Targets.

Authors:  Roberto Adamo; Immaculada Margarit
Journal:  mBio       Date:  2018-05-15       Impact factor: 7.867

Review 9.  Migrant and refugee populations: a public health and policy perspective on a continuing global crisis.

Authors:  Mohamed Abbas; Tammam Aloudat; Javier Bartolomei; Manuel Carballo; Sophie Durieux-Paillard; Laure Gabus; Alexandra Jablonka; Yves Jackson; Kanokporn Kaojaroen; Daniel Koch; Esperanza Martinez; Marc Mendelson; Roumyana Petrova-Benedict; Sotirios Tsiodras; Derek Christie; Mirko Saam; Sally Hargreaves; Didier Pittet
Journal:  Antimicrob Resist Infect Control       Date:  2018-09-20       Impact factor: 4.887

10.  2018 Survey of factors associated with antimicrobial drug use and stewardship practices in adult cows on conventional California dairies: immediate post-Senate Bill 27 impact.

Authors:  Pius S Ekong; Essam M Abdelfattah; Emmanuel Okello; Deniece R Williams; Terry W Lehenbauer; Betsy M Karle; Joan D Rowe; Sharif S Aly
Journal:  PeerJ       Date:  2021-07-13       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.